RECRUITING

Local Anesthesia for Facial Fractures

Description

The study is a double-blind randomized, placebo controlled trial examining the impact of perioperative bupivacaine nerve block on PACU recovery metrics. Patients with operative facial fractures are randomized to receive either bupivacaine or saline injections prior to the anesthesia emergence.

Conditions

Study Overview

Study Details

Study overview

The study is a double-blind randomized, placebo controlled trial examining the impact of perioperative bupivacaine nerve block on PACU recovery metrics. Patients with operative facial fractures are randomized to receive either bupivacaine or saline injections prior to the anesthesia emergence.

The Impact of Perioperative Nerve Block on Opioid Use After Craniomaxillofacial Trauma Surgery: A Randomized Controlled Trial

Local Anesthesia for Facial Fractures

Condition
Pain Management
Intervention / Treatment

-

Contacts and Locations

Saint Louis

Washington University, Saint Louis, Missouri, United States, 63110

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Adults age 18 and over
  • 2. Isolated facial fracture to the mandible and/or midface undergoing surgical repair
  • 3. No allergy to local anesthetic
  • 4. Ability to read, write, and understand English
  • 1. Patients under the age of 18
  • 2. Isolated nasal bone fracture
  • 3. Polytrauma (I.e. injury pattern resulting in hospital admission for multiple bony fractures outside of the face)
  • 4. Allergy to local anesthetic

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Washington University School of Medicine,

Amrita Hari_Raj, MD, PRINCIPAL_INVESTIGATOR, Washington University School of Medicine

Jay Piccirillo, MD, STUDY_DIRECTOR, Washington University School of Medicine

Study Record Dates

2025-07-01